Who is the CEO of Cadila Pharma?
Dr. Rajiv I. Modi is the Chairman and Managing Director of Cadila Pharmaceuticals Ltd., one of India’s largest privately held pharmaceutical companies founded by his father Shri Indravadan A. Modi in 1951.
Is Cadila Pharma a good company?
Cadila Pharmaceuticals is rated 4.0 out of 5, based on 6.2k reviews by employees on AmbitionBox. Cadila Pharmaceuticals is known for Skill development which is rated at the top and given a rating of 4.0. However, Career growth is rated the lowest at 3.6 and can be improved.
Is Cadila a generic company?
Cadila Healthcare, like its other namesake Cadila Pharmaceutical, has been a major player in the generics market — the industry that put India on the world map.
Is Cadila and Zydus same?
The Zydus group on Thursday announced its new brand identity with the name of the listed entity of the group Cadila Healthcare Ltd. being changed to Zydus Lifesciences Ltd.
Is Cadila a name change?
Who is the biggest pharma company in India?
Sun Pharma
By market capitalization
| Rank | Company | Market capitalization (January 2022) |
|---|---|---|
| 1 | Sun Pharma | ₹198,484 crore (US$26 billion) |
| 2 | Divi’s Laboratories | ₹104,642 crore (US$14 billion) |
| 3 | Cipla | ₹75,206 crore (US$9.9 billion) |
| 4 | Dr. Reddy’s Laboratories | ₹70,193 crore (US$9.2 billion) |
Who is the owner of Intas pharma?
Hasmukh Chudgar
Low profile Hasmukh Chudgar founded generics maker Intas Pharmaceuticals in 1977. Chudgar has long handed over operations to his sons Nimish and Binish, who run the $2.2 billion (revenue) company. Intas operates 15 factories of which 10 are in India and the rest in Europe and Mexico.
How big is intas?
Financials. The company had an annual revenue of US$1.8 Billion (₹12,600 crore) in 2019 and a profit of $204 Million (₹1,248 crore) after taxes in the financial year 2019. The company’s 69% of revenue came from international operations in the FY2019 while 31% came from India.